Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_21050 | 18 | 0.37 | Mlig455_024510 | Neo: - Age: - |
Mlig455_024510 {REF} {Length: 2499} {RNA1310_68107} {RNA815_59638} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 0.955 | 0.675 | 0.99952 | 1.00000 | |
RegionR2 | 1.254 | 0.675 | 0.99987 | 1.00000 | |
RegionR3 | -0.885 | 0.675 | 0.99986 | 1.00000 | |
RegionR4 | -0.851 | 0.675 | 0.99975 | 1.00000 | |
RegionR5 | -1.562 | 0.675 | 0.99979 | 1.00000 | |
RegionR6 | -0.736 | 0.675 | 0.99977 | 1.00000 | |
RegionR7 | 0.95 | 0.675 | 0.99993 | 1.00000 | |
RegionR8 | 0.875 | 0.675 | 0.99991 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 0.566 | 0.675 | 0.99993 | 1.00000 | |
RegenerationR2 | 2.814 | 0.675 | 0.00106 | 0.04831 | |
RegenerationR3 | 4.938 | 0.675 | 0.00103 | 0.05087 | |
RegenerationR4 | 2.434 | 0.675 | 0.00393 | 0.08586 | |
RegenerationR5 | 3.143 | 0.675 | 0.00139 | 0.06359 | |
RegenerationR6 | 0.823 | 0.675 | 0.99985 | 1.00000 | |
RegenerationBL | 0.13 | 0.675 | 0.99990 | 1.00000 | |
RegenerationTP | 3.973 | 0.675 | 0.00459 | 0.11271 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_21050 | 18 | 0.37 | Mlig455_024510 | Neo: - Age: - |
2 | - | - | - | - | 1.000 | 1.000 | Mlig455_024510 {REF} {Length: 2499} {RNA1310_68107} {RNA815_59638} | |
2. | MligTC455_54226 | 52 | 1.09 | Mlig455_037435, Mlig455_037458 | Neo: - Age: - |
NETO2 | 1.678 | - | - | - | - | 0.722 | 0.956 | Mlig455_037435 {REF} {Length: 2663} {Pfam: CUB domain [PF00431.22, score=52.2]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [Score=96.3, Expect=3e-20]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [Score=97.8, Expect=6e-21]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=87.8, Expect=1e-17]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=77.4, Expect=4e-15]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=87.0, Expect=1e-17]} {RNA1310_38111} Mlig455_037458 {REF} {Length: 2349} {Pfam: CUB domain [PF00431.22, score=52.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [RH, Score=144, Expect=9e-37]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [RH, Score=146, Expect=1e-37]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=117, Expect=2e-27]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=105, Expect=1e-24]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=115, Expect=6e-27]} {RNA1310_38111} |
3. | MligTC455_49870 | 86 | 1.8 | Mlig455_028362, Mlig455_067454, Mlig455_067455 | Neo: - Age: - |
CHRM1, CHRM4 | 0.985 | - | - | - | - | - | 0.985 | Mlig455_028362 {REF} {Length: 3223} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=40.4]} {Human: ENSG00000168539, CHRM1, cholinergic receptor muscarinic 1, [Score=98.2, Expect=2e-21]; ENSG00000180720, CHRM4, cholinergic receptor muscarinic 4, [Score=94.7, Expect=3e-20]} {Mouse: ENSMUSG00000032773, Chrm1, cholinergic receptor, muscarinic 1, CNS, [Score=97.4, Expect=2e-21]; ENSMUSG00000040495, Chrm4, cholinergic receptor, muscarinic 4, [Score=94.7, Expect=2e-20]} {Dmel: FBgn0037546, mAChR-B, muscarinic Acetylcholine Receptor, B-type, [Score=136, Expect=5e-34]} {Celegans: WBGene00001518, gar-2, Probable muscarinic acetylcholine receptor gar-2, [RH, Score=128, Expect=4e-33]} {Smed: dd_Smed_v6_37337_0_1, dd_Smed_v6_37337_0_1, [RH, Score=149, Expect=1e-42]} {RNA1310_12338} {RNA815_37088} Mlig455_067454 {REF} {Length: 1188} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=103.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=29.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.2]} {Human: ENSG00000180720, CHRM4, cholinergic receptor muscarinic 4, [Score=102, Expect=2e-23]; ENSG00000168539, CHRM1, cholinergic receptor muscarinic 1, [Score=97.1, Expect=1e-21]} {Mouse: ENSMUSG00000040495, Chrm4, cholinergic receptor, muscarinic 4, [Score=103, Expect=6e-24]} {Dmel: FBgn0037546, mAChR-B, muscarinic Acetylcholine Receptor, B-type, [Score=189, Expect=1e-53]} {Celegans: WBGene00001518, gar-2, Probable muscarinic acetylcholine receptor gar-2, [Score=133, Expect=3e-34]} {Smed: dd_Smed_v6_24759_0_1, dd_Smed_v6_24759_0_1, [Score=225, Expect=7e-69]} {RNA1310_12338} {RNA815_52171} Mlig455_067455 {REF} {Length: 2697} {RNA1310_12338} {RNA815_37088} |
4. | MligTC455_20910 | 10 | 0.22 | Mlig455_039653 | Neo: - Age: - |
0.98 | - | - | - | - | 0.980 | - | Mlig455_039653 {REF} {Length: 1234} {RNA1509_48033} {RNA1310_47692} {RNA815_51419} | |
5. | MligTC455_51820 | 83 | 1.72 | Mlig455_023927 | Neo: - Age: - |
TCAF2C | 0.977 | - | - | - | - | - | 0.977 | Mlig455_023927 {REF} {Length: 2841} {Pfam: Peptidase M60, enhancin and enhancin-like [PF13402.8, score=147.1]; N-terminal domain of M60-like peptidases [PF17291.4, score=51.5]} {Human: ENSG00000283528, TCAF2C, TRPM8 channel associated factor 2C, [RH, Score=297, Expect=2e-89]; ENSG00000170379, TCAF2, TRPM8 channel associated factor 2, [RH, Score=292, Expect=6e-86]} {Mouse: ENSMUSG00000029851, Tcaf2, TRPM8 channel-associated factor 2, [RH, Score=284, Expect=4e-83]} {Smed: dd_Smed_v6_13298_0_1, dd_Smed_v6_13298_0_1, [RH, Score=116, Expect=1e-26]} {RNA1509_48809} {RNA1310_14523, RNA1509_48809} {RNA1509_48809, RNA815_23113} |
6. | MligTC455_39978 | 270 | 5.62 | Mlig455_052261, Mlig455_052349 | Neo: - Age: Down-Up-Up Region-enriched R8: 3.650/0.00368 |
0.973 | - | - | - | - | - | 0.973 | Mlig455_052261 {REF} {Length: 760} {RNA1310_41850} {RNA815_20313} Mlig455_052349 {REF} {Length: 710} {RNA1310_41850} {RNA815_20313} |
|
7. | MligTC455_30845 | 20 | 0.41 | Mlig455_011948 | Neo: - Age: Up-Down-Up |
CRB1 | 0.972 | - | - | - | - | 0.972 | - | Mlig455_011948 {REF} {Length: 2732} {Human: ENSG00000134376, CRB1, crumbs 1, cell polarity complex component, [Score=62.0, Expect=1e-09]} {Mouse: ENSMUSG00000021614, Vcan, versican, [Score=57.0, Expect=3e-08]; ENSMUSG00000014773, Dll1, delta like canonical Notch ligand 1, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0259685, crb, crumbs, [Score=57.0, Expect=2e-08]} {Celegans: WBGene00003001, lin-12, [Score=47.4, Expect=1e-05]} {Smed: dd_Smed_v6_11876_0_1, dd_Smed_v6_11876_0_1, [Score=52.0, Expect=5e-07]} {RNA1509_37192} {RNA1310_27038} {RNA815_4589.1} |
8. | MligTC455_21260 | 301 | 6.27 | Mlig455_014876, Mlig455_015000, Mlig455_038652 | Neo: - Age: - |
MFSD2A | 0.97 | - | - | - | - | - | 0.970 | Mlig455_014876 {REF} {Length: 2654} {Pfam: MFS/sugar transport protein [PF13347.8, score=240.7]} {Human: ENSG00000168389, MFSD2A, major facilitator superfamily domain containing 2A, [Score=224, Expect=3e-66]} {Mouse: ENSMUSG00000028655, Mfsd2a, major facilitator superfamily domain containing 2A, [Score=216, Expect=3e-63]} {Smed: dd_Smed_v6_11210_0_1, dd_Smed_v6_11210_0_1, [Score=226, Expect=3e-67]} {RNA1310_11647} {RNA815_7111} Mlig455_015000 {REF} {Length: 3198} {Pfam: MFS/sugar transport protein [PF13347.8, score=239.2]} {Human: ENSG00000168389, MFSD2A, major facilitator superfamily domain containing 2A, [Score=225, Expect=2e-66]} {Mouse: ENSMUSG00000028655, Mfsd2a, major facilitator superfamily domain containing 2A, [Score=221, Expect=3e-65]} {Smed: dd_Smed_v6_11210_0_1, dd_Smed_v6_11210_0_1, [Score=228, Expect=9e-68]} {RNA1509_13138} {RNA1310_11647} {RNA815_7111} Mlig455_038652 {REF} {Length: 3844} {RNA1509_56255} {RNA1310_12002} {RNA815_7111} |
9. | MligTC455_22133 | 5172 | 107.76 | Mlig455_005007, Mlig455_005046, Mlig455_005262 | Neo: - Age: logFC(26M/2M)=-0.260 Region-enriched R7: 1.553/0.00000 Regeneration-downregulated BL: -2.126 Regeneration-depleted BL: -2.126 |
CPS1 | 0.97 | - | - | - | - | - | 0.970 | Mlig455_005007 {REF} {Length: 5305} {TRANSSPLICED} {Pfam: Carbamoyl-phosphate synthase L chain, ATP binding domain [PF02786.19, score=368.5]; Carbamoyl-phosphate synthase small chain, CPSase domain [PF00988.24, score=165.1]; Glutamine amidotransferase class-I [PF00117.30, score=131.3]; Carbamoyl-phosphate synthetase large chain, oligomerisation domain [PF02787.21, score=78.8]; D-ala D-ala ligase C-terminus [PF07478.15, score=63.3]; ATP-grasp domain [PF02222.24, score=63.2]; MGS-like domain [PF02142.24, score=48.6]; ATP-grasp in the biosynthetic pathway with Ter operon [PF15632.8, score=42.5]; Peptidase C26 [PF07722.15, score=18.5]} {Human: ENSG00000021826, CPS1, carbamoyl-phosphate synthase 1, [RH, Score=1884, Expect=0.0]} {Mouse: ENSMUSG00000025991, Cps1, carbamoyl-phosphate synthetase 1, [RH, Score=1883, Expect=0.0]} {Dmel: FBgn0003189, r, rudimentary, [Score=1486, Expect=0.0]} {Celegans: WBGene00004259, pyr-1, CAD protein Glutamine-dependent carbamoyl-phosphate synthase Aspartate carbamoyltransferase Dihydroorotase, [Score=1449, Expect=0.0]} {Smed: dd_Smed_v6_4349_0_1, dd_Smed_v6_4349_0_1, [RH, Score=2173, Expect=0.0]} {RNA1509_878} {RNA1310_1011.1} {RNA815_289.1} Mlig455_005046 {REF} {Length: 5312} {TRANSSPLICED} {Pfam: Carbamoyl-phosphate synthase L chain, ATP binding domain [PF02786.19, score=368.7]; Carbamoyl-phosphate synthase small chain, CPSase domain [PF00988.24, score=165.0]; Glutamine amidotransferase class-I [PF00117.30, score=131.4]; Carbamoyl-phosphate synthetase large chain, oligomerisation domain [PF02787.21, score=78.8]; D-ala D-ala ligase C-terminus [PF07478.15, score=63.5]; ATP-grasp domain [PF02222.24, score=63.3]; ATP-grasp in the biosynthetic pathway with Ter operon [PF15632.8, score=42.7]; Peptidase C26 [PF07722.15, score=18.6]} {Human: ENSG00000021826, CPS1, carbamoyl-phosphate synthase 1, [Score=1772, Expect=0.0]} {Mouse: ENSMUSG00000025991, Cps1, carbamoyl-phosphate synthetase 1, [Score=1772, Expect=0.0]} {Dmel: FBgn0003189, r, rudimentary, [Score=1425, Expect=0.0]} {Celegans: WBGene00004259, pyr-1, CAD protein Glutamine-dependent carbamoyl-phosphate synthase Aspartate carbamoyltransferase Dihydroorotase, [Score=1392, Expect=0.0]} {Smed: dd_Smed_v6_4349_0_1, dd_Smed_v6_4349_0_1, [Score=2044, Expect=0.0]} {RNA1509_878} {RNA1310_1011.1, RNA1509_878} {RNA1509_878, RNA815_289.1} Mlig455_005262 {REF} {Length: 5315} {TRANSSPLICED} {Pfam: Carbamoyl-phosphate synthase L chain, ATP binding domain [PF02786.19, score=368.5]; Carbamoyl-phosphate synthase small chain, CPSase domain [PF00988.24, score=165.1]; Glutamine amidotransferase class-I [PF00117.30, score=131.3]; Carbamoyl-phosphate synthetase large chain, oligomerisation domain [PF02787.21, score=78.8]; D-ala D-ala ligase C-terminus [PF07478.15, score=63.3]; ATP-grasp domain [PF02222.24, score=63.2]; MGS-like domain [PF02142.24, score=48.6]; ATP-grasp in the biosynthetic pathway with Ter operon [PF15632.8, score=42.5]; Peptidase C26 [PF07722.15, score=18.5]} {Human: ENSG00000021826, CPS1, carbamoyl-phosphate synthase 1, [RH, Score=1884, Expect=0.0]} {Mouse: ENSMUSG00000025991, Cps1, carbamoyl-phosphate synthetase 1, [RH, Score=1883, Expect=0.0]} {Dmel: FBgn0003189, r, rudimentary, [Score=1486, Expect=0.0]} {Celegans: WBGene00004259, pyr-1, CAD protein Glutamine-dependent carbamoyl-phosphate synthase Aspartate carbamoyltransferase Dihydroorotase, [Score=1449, Expect=0.0]} {Smed: dd_Smed_v6_4349_0_1, dd_Smed_v6_4349_0_1, [RH, Score=2173, Expect=0.0]} {RNA1509_878} {RNA1310_1011.1} {RNA815_289.1} |
10. | MligTC455_24244 | 290 | 6.04 | Mlig455_062623, Mlig455_067528, Mlig455_070336 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.603/0.00020 |
0.97 | - | - | - | - | - | 0.970 | Mlig455_062623 {REF} {Length: 1154} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=68.1]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=71.6, Expect=3e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_067528 {REF} {Length: 1190} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.0]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=72.4, Expect=1e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_070336 {REF} {Length: 859} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.7]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [Score=57.4, Expect=1e-10]} {RNA1310_40891} {RNA815_16565} |
|
11. | MligTC455_27969 | 203 | 4.24 | Mlig455_055219, Mlig455_055313 | Neo: - Age: - |
ADARB1 | 0.97 | - | - | - | - | 0.970 | - | Mlig455_055219 {REF} {Length: 3087} {TRANSSPLICED} {Pfam: Adenosine-deaminase (editase) domain [PF02137.20, score=288.8]; Double-stranded RNA binding motif [PF00035.28, score=44.8]} {Human: ENSG00000197381, ADARB1, adenosine deaminase, RNA specific B1, [RH, Score=346, Expect=9e-110]} {Mouse: ENSMUSG00000020262, Adarb1, adenosine deaminase, RNA-specific, B1, [RH, Score=358, Expect=3e-114]} {Dmel: FBgn0026086, Adar, Adenosine deaminase acting on RNA, [RH, Score=296, Expect=2e-91]} {Celegans: WBGene00000080, adr-2, Probable double-stranded RNA-specific adenosine deaminase, [RH, Score=184, Expect=2e-51]} {Smed: dd_Smed_v6_4538_0_1, dd_Smed_v6_4538_0_1, [RH, Score=235, Expect=5e-68]} {RNA1509_57256} {RNA1310_8624} {RNA815_8285} Mlig455_055313 {REF} {Length: 2868} {TRANSSPLICED} {Pfam: Adenosine-deaminase (editase) domain [PF02137.20, score=289.4]; Double-stranded RNA binding motif [PF00035.28, score=44.8]} {Human: ENSG00000197381, ADARB1, adenosine deaminase, RNA specific B1, [RH, Score=347, Expect=5e-110]} {Mouse: ENSMUSG00000020262, Adarb1, adenosine deaminase, RNA-specific, B1, [RH, Score=356, Expect=1e-113]} {Dmel: FBgn0026086, Adar, Adenosine deaminase acting on RNA, [RH, Score=290, Expect=8e-89]} {Celegans: WBGene00000080, adr-2, Probable double-stranded RNA-specific adenosine deaminase, [RH, Score=184, Expect=3e-51]} {Smed: dd_Smed_v6_4538_0_1, dd_Smed_v6_4538_0_1, [RH, Score=236, Expect=3e-68]} {RNA1509_57256, RNA1509_57608} {RNA1310_8624, RNA1509_57256, RNA1509_57608} {RNA1509_57256, RNA1509_57608, RNA815_8285} |
12. | MligTC455_56624 | 8 | 0.17 | Mlig455_034946 | Neo: - Age: - |
0.967 | - | - | - | - | 0.967 | - | Mlig455_034946 {REF} {Length: 329} {NoTransDecoderORF} {RNA1310_78916} {RNA815_63138} | |
13. | MligTC455_11279 | 35 | 0.73 | Mlig455_013960 | Neo: - Age: - |
ANK1 | 0.965 | - | - | - | - | 0.965 | - | Mlig455_013960 {REF} {Length: 3851} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=175.9]; Ankyrin repeats (many copies) [PF13637.8, score=158.1]; Ankyrin repeats (many copies) [PF13857.8, score=137.2]; Ankyrin repeat [PF00023.32, score=134.2]; Ankyrin repeat [PF13606.8, score=115.0]; Mab-21 protein [PF03281.16, score=28.0]} {Human: ENSG00000029534, ANK1, ankyrin 1, [Score=171, Expect=9e-43]; ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=168, Expect=7e-42]} {Mouse: ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=173, Expect=1e-43]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=192, Expect=1e-49]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=162, Expect=2e-40]} {Smed: dd_Smed_v6_2072_0_2, dd_Smed_v6_2072_0_2, [Score=150, Expect=9e-37]} |
14. | MligTC455_25152 | 168 | 3.51 | Mlig455_040072 | Neo: - Age: - Region-enriched R8: 4.101/0.00210 |
0.963 | - | - | - | - | - | 0.963 | Mlig455_040072 {REF} {Length: 2067} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=43.4]; TcdA/TcdB catalytic glycosyltransferase domain [PF12919.9, score=22.9]} {Smed: dd_Smed_v6_32358_0_1, dd_Smed_v6_32358_0_1, [Score=57.8, Expect=1e-09]} {RNA1509_20770} {RNA1310_38403} {RNA815_6249} | |
15. | MligTC455_06500 | 15 | 0.31 | Mlig455_025797 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_025797 {REF} {Length: 1697} {NoTransDecoderORF} {RNA1509_54874} {RNA1310_106012} | |
16. | MligTC455_37668 | 16 | 0.32 | Mlig455_056257 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_056257 {REF} {Length: 2106} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=19.7]} {Smed: dd_Smed_v6_129_2_1, dd_Smed_v6_129_2_1, [Score=86.7, Expect=6e-18]} {RNA1509_42704} {RNA1310_21353.2} {RNA815_9313} | |
17. | MligTC455_49910 | 39 | 0.81 | Mlig455_070409 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_070409 {REF} {Length: 4207} {RNA1509_10844} {RNA1310_32867} {RNA815_30370} | |
18. | MligTC455_13126 | 16 | 0.33 | Mlig455_006139 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_006139 {REF} {Length: 2169} {NoTransDecoderORF} {RNA1509_46209} {RNA1310_76341} {RNA815_45428} | |
19. | MligTC455_26773 | 225 | 4.68 | Mlig455_038010 | Neo: - Age: logFC(26M/2M)=-0.420 Region-enriched R7: 3.223/0.00025 |
ANO7 | 0.956 | - | - | - | - | - | 0.956 | Mlig455_038010 {REF} {Length: 4566} {Pfam: Calcium-activated chloride channel [PF04547.14, score=519.7]; Dimerisation domain of Ca+-activated chloride-channel, anoctamin [PF16178.7, score=242.9]} {Human: ENSG00000146205, ANO7, anoctamin 7, [RH, Score=874, Expect=0.0]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [RH, Score=885, Expect=0.0]} {Dmel: FBgn0038721, subdued, [RH, Score=594, Expect=0.0]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [Score=242, Expect=9e-68]} {Smed: dd_Smed_v6_4761_0_1, dd_Smed_v6_4761_0_1, [RH, Score=1090, Expect=0.0]} {RNA1509_15570} {RNA1310_5583.1, RNA1509_15570} {RNA1509_15570, RNA815_1646.1} |
20. | MligTC455_31059 | 571 | 11.9 | Mlig455_013389 | Neo: - Age: - Region-enriched R7: 2.543/0.00000 Regeneration-downregulated BL: -2.866 Regeneration-depleted BL: -2.866 |
0.956 | - | - | - | - | - | 0.956 | Mlig455_013389 {REF} {Length: 3375} {Pfam: Profilin [PF00235.21, score=45.7]} {Smed: dd_Smed_v6_6034_0_1, dd_Smed_v6_6034_0_1, [RH, Score=79.3, Expect=5e-17]} {RNA1509_42370} {RNA1310_22792.1} {RNA815_5445} | |
21. | MligTC455_26833 | 22 | 0.46 | Mlig455_048301 | Neo: - Age: - |
OPLAH | 0.954 | - | - | - | - | 0.954 | - | Mlig455_048301 {REF} {Length: 4436} {Pfam: Hydantoinase B/oxoprolinase [PF02538.16, score=626.3]; Hydantoinase/oxoprolinase [PF01968.20, score=350.5]; Hydantoinase/oxoprolinase N-terminal region [PF05378.15, score=203.7]; Hydantoinase/oxoprolinase C-terminal domain [PF19278.1, score=36.1]} {Human: ENSG00000178814, OPLAH, 5-oxoprolinase, ATP-hydrolysing, [RH, Score=1454, Expect=0.0]} {Mouse: ENSMUSG00000022562, Oplah, 5-oxoprolinase (ATP-hydrolysing), [RH, Score=1424, Expect=0.0]} {Dmel: FBgn0034733, CG4752, [RH, Score=1391, Expect=0.0]} {Celegans: WBGene00021430, Y38F2AR.12, [RH, Score=1409, Expect=0.0]} {Smed: dd_Smed_v6_5008_0_1, dd_Smed_v6_5008_0_1, [Score=989, Expect=0.0]} {RNA1509_2948, RNA1509_37889} {RNA1310_1508.1, RNA1509_37889} {RNA1509_37889, RNA815_468} |
22. | MligTC455_47805 | 309 | 6.43 | Mlig455_002866, Mlig455_033201 | Neo: - |
NR2C2 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_002866 {REF} {Length: 2397} {RNA1509_25172} {RNA1310_17963.1} {RNA815_11681} Mlig455_033201 {REF} {Length: 2405} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=86.4]} {Human: ENSG00000177463, NR2C2, nuclear receptor subfamily 2 group C member 2, [Score=90.5, Expect=1e-18]; ENSG00000120798, NR2C1, nuclear receptor subfamily 2 group C member 1, [Score=87.8, Expect=4e-18]; ENSG00000101076, HNF4A, hepatocyte nuclear factor 4 alpha, [Score=87.4, Expect=7e-18]; ENSG00000113580, NR3C1, nuclear receptor subfamily 3 group C member 1, [Score=87.4, Expect=2e-17]; ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [Score=87.0, Expect=6e-18]; ENSG00000160113, NR2F6, nuclear receptor subfamily 2 group F member 6, [Score=86.7, Expect=9e-18]; ENSG00000151623, NR3C2, nuclear receptor subfamily 3 group C member 2, [Score=86.7, Expect=3e-17]} {Mouse: ENSMUSG00000005893, Nr2c2, nuclear receptor subfamily 2, group C, member 2, [Score=88.2, Expect=5e-18]; ENSMUSG00000017950, Hnf4a, hepatic nuclear factor 4, alpha, [Score=88.2, Expect=3e-18]; ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [Score=87.0, Expect=5e-18]; ENSMUSG00000031618, Nr3c2, nuclear receptor subfamily 3, group C, member 2, [Score=87.0, Expect=1e-17]; ENSMUSG00000005897, Nr2c1, nuclear receptor subfamily 2, group C, member 1, [Score=86.7, Expect=1e-17]; ENSMUSG00000002393, Nr2f6, nuclear receptor subfamily 2, group F, member 6, [Score=85.9, Expect=9e-18]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [Score=85.1, Expect=2e-17]; ENSMUSG00000023034, Nr4a1, nuclear receptor subfamily 4, group A, member 1, [Score=85.1, Expect=4e-17]; ENSMUSG00000024431, Nr3c1, nuclear receptor subfamily 3, group C, member 1, [Score=85.1, Expect=5e-17]; ENSMUSG00000026398, Nr5a2, nuclear receptor subfamily 5, group A, member 2, [Score=84.3, Expect=7e-17]} {Dmel: FBgn0264562, Hr4, Hormone receptor 4, [Score=96.3, Expect=1e-20]} {Celegans: WBGene00003681, nhr-91, Nuclear hormone receptor family member nhr-91, [Score=89.7, Expect=5e-19]} {Smed: dd_Smed_v6_33286_0_2, dd_Smed_v6_33286_0_2, [Score=86.7, Expect=6e-19]} {RNA1509_25172} {RNA1310_17963.1, RNA1509_25172} {RNA1509_25172, RNA815_11681} |
23. | MligTC455_26366 | 75 | 1.56 | Mlig455_013893 | Neo: - Age: - |
NSUN7 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_013893 {REF} {Length: 1904} {Human: ENSG00000179299, NSUN7, NOP2/Sun RNA methyltransferase family member 7, [Score=167, Expect=4e-45]} {Mouse: ENSMUSG00000029206, Nsun7, NOL1/NOP2/Sun domain family, member 7, [Score=164, Expect=3e-44]} {Dmel: FBgn0266099, CG44836, [Score=72.8, Expect=2e-13]} {Celegans: WBGene00013151, nsun-5, Nop2 (NOP2)/SUN domain family member, [Score=56.2, Expect=2e-08]} {Smed: dd_Smed_v6_30093_0_1, dd_Smed_v6_30093_0_1, [Score=203, Expect=3e-60]} {RNA1310_17601} {RNA815_32144} |
24. | MligTC455_30510 | 11 | 0.22 | Mlig455_055207 | Neo: - Age: - |
PPFIBP1 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_055207 {REF} {Length: 3280} {Pfam: SAM domain (Sterile alpha motif) [PF07647.19, score=70.1]; SAM domain (Sterile alpha motif) [PF00536.32, score=49.7]; TolA binding protein trimerisation [PF16331.7, score=19.1]} {Human: ENSG00000110841, PPFIBP1, PPFIA binding protein 1, [RH, Score=198, Expect=8e-54]; ENSG00000166387, PPFIBP2, PPFIA binding protein 2, [RH, Score=192, Expect=4e-52]} {Mouse: ENSMUSG00000016487, Ppfibp1, PTPRF interacting protein, binding protein 1 (liprin beta 1), [RH, Score=197, Expect=5e-53]; ENSMUSG00000036528, Ppfibp2, PTPRF interacting protein, binding protein 2 (liprin beta 2), [RH, Score=194, Expect=5e-52]} {Dmel: FBgn0036376, Liprin-beta, [RH, Score=179, Expect=1e-47]} {Celegans: WBGene00011904, hlb-1, Liprin-beta, [RH, Score=155, Expect=4e-39]} {Smed: dd_Smed_v6_7610_0_2, dd_Smed_v6_7610_0_2, [RH, Score=204, Expect=1e-56]} {RNA1509_21478} {RNA1310_4697} {RNA815_6558} |
25. | MligTC455_42559 | 17 | 0.36 | Mlig455_064128 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_064128 {REF} {Length: 1837} {Pfam: Glycine rich protein [PF12810.9, score=23.2]} {RNA1310_112308} {RNA815_32418} | |
26. | MligTC455_00291 | 4 | 0.08 | Mlig455_041817 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_041817 {REF} {Length: 137} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_50573} {RNA1310_17892.1} | |
27. | MligTC455_09448 | 18 | 0.38 | Mlig455_060229 | Neo: - Age: - Regeneration-upregulated R2: 5.386 Regeneration-enriched R2: 5.386 |
0.952 | - | - | - | - | 0.952 | - | Mlig455_060229 {REF} {Length: 994} {NoTransDecoderORF} {RNA1310_62102} | |
28. | MligTC455_06332 | 14 | 0.28 | Mlig455_057922 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_057922 {REF} {Length: 345} {NoTransDecoderORF} {RNA1310_58645} {RNA815_60376} | |
29. | MligTC455_27968 | 139 | 2.9 | Mlig455_006102 | Neo: - Age: - |
SYNCRIP | 0.95 | - | - | - | - | 0.950 | - | Mlig455_006102 {REF} {Length: 3069} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=86.6]; Double-stranded RNA binding motif [PF00035.28, score=67.2]; Occluded RNA-recognition motif [PF16842.7, score=20.3]} {Human: ENSG00000135316, SYNCRIP, synaptotagmin binding cytoplasmic RNA interacting protein, [Score=189, Expect=7e-52]} {Mouse: ENSMUSG00000032423, Syncrip, synaptotagmin binding, cytoplasmic RNA interacting protein, [Score=188, Expect=1e-51]} {Dmel: FBgn0038826, Syp, Syncrip, [Score=223, Expect=4e-63]} {Celegans: WBGene00015943, tiar-1, TIA-1/TIAL RNA binding protein homolog, [Score=63.9, Expect=2e-10]} {Smed: dd_Smed_v6_62256_0_1, dd_Smed_v6_62256_0_1, [Score=144, Expect=4e-37]} {RNA1509_30609} {RNA1310_8624} {RNA815_8285} |
30. | MligTC455_32534 | 166 | 3.46 | Mlig455_034593, Mlig455_040890 | Neo: - Age: - Region-enriched R4: 2.124/0.04916 |
0.95 | - | - | - | - | 0.950 | - | Mlig455_034593 {REF} {Length: 1979} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_46555} {RNA1310_8675} {RNA815_3094.1} Mlig455_040890 {REF} {Length: 980} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_23515} {RNA1310_8675} {RNA815_3094.1} |